Sugi Predict

Sugi Predict / Compounds / SCHEMBL3494264

SCHEMBL3494264

SCHEMBL3494264

COCCN1C(=O)COc2cc(-c3ccccc3Nc3ncc(C#N)c(NC4CC(C)(C)N(C)C(C)(C)C4)n3)cnc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 10/20 0.36
▸ CSNK2A2 P19784 3/20 0.35
▸ CSNK2A1 P68400 3/20 0.35
▸ PKMYT1 Q99640 2/20 0.34
▸ EGFR P00533 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CLK4 Q9HAZ1 1/20 0.33
▸ PRKCQ Q04759 1/20 0.32
▸ RET P07949 1/20 0.32
▸ KIF5B P33176 1/20 0.32
▸ KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3495366 0.91 CSNK2A2 (0.35) LRRK2CSNK2A2CSNK2A1PKMYT1EGFR
SCHEMBL3496258 0.90 PRKCQ (0.41) LRRK2EGFRPRKCQRETKIF5B
SCHEMBL3495241 0.90 LRRK2 (0.36) LRRK2CSNK2A2CSNK2A1PKMYT1EGFR
SCHEMBL3495361 0.88 SYK (0.45) —
SCHEMBL3496130 0.84 CSNK2A2 (0.35) LRRK2CSNK2A2CSNK2A1PKMYT1EGFR
SCHEMBL3495502 0.83 LRRK2 (0.35) LRRK2CSNK2A2CSNK2A1PKMYT1EGFR
SCHEMBL3496148 0.81 PRKCQ (0.41) LRRK2CSNK2A2CSNK2A1EGFRPRKCQ
SCHEMBL3497184 0.81 SYK (0.45) —
SCHEMBL3494271 0.80 CYP1A2 (0.42) MEN1USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL3496415 0.80 PRKCQ (0.41) LRRK2EGFRPRKCQRETKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. 2010-05-27 — — US claimed
EP-2183225-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2010-05-12 — — EP claimed
WO-2009012421-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2009-01-22 — — WO claimed
US-8993585-B2 Cyclic amine substituted pyrimidinediamines as PKC inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2015-03-31 — — US disclosed
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. 2010-05-27 — — US disclosed
EP-2183225-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2010-05-12 — — EP disclosed
WO-2009012421-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2009-01-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS PRKCH, PKD2, PRKCQ LRRK2 311/4885CSNK2A2 643/4885CSNK2A1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.